Gilead Sciences (GILD) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $9.0 million.
- Gilead Sciences' Long-Term Debt Repayments fell 9196.43% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 896.59%. This contributed to the annual value of $2.0 billion for FY2024, which is 1244.44% down from last year.
- Per Gilead Sciences' latest filing, its Long-Term Debt Repayments stood at $9.0 million for Q3 2025, which was down 9196.43% from $9.0 million recorded in Q2 2025.
- Gilead Sciences' 5-year Long-Term Debt Repayments high stood at $2.5 billion for Q3 2021, and its period low was $7.0 million during Q4 2024.
- Moreover, its 5-year median value for Long-Term Debt Repayments was $1.0 billion (2021), whereas its average is $1.0 billion.
- Its Long-Term Debt Repayments has fluctuated over the past 5 years, first soared by 15000.0% in 2021, then plummeted by 9951.38% in 2025.
- Gilead Sciences' Long-Term Debt Repayments (Quarter) stood at $1.0 billion in 2021, then changed by 0.0% to $1.0 billion in 2022, then soared by 125.0% to $2.2 billion in 2023, then tumbled by 99.69% to $7.0 million in 2024, then increased by 28.57% to $9.0 million in 2025.
- Its last three reported values are $9.0 million in Q3 2025, $9.0 million for Q2 2025, and $1.8 billion during Q1 2025.